相关实验视频

Updated: Jul 24, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

我们可以依靠机器学习算法作为高度质瘤复发的可靠预测指标吗? 一个系统的审查和元分析

Ibrahim Mohammadzadeh¹, Behnaz Niroomand¹, Bardia Hajikarimloo²

¹Skull Base Research Center, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Clinical neurology and neurosurgery

|January 30, 2025

概括

机器学习 (ML) 有效地区分高度质瘤复发与治疗效应. 支持矢量机 (SVM) 显示出高精度,有助于早期诊断和患者管理.

科学领域:

神经瘤学神经瘤学
医学成像分析分析医学成像分析
医学中的人工智能.

背景情况:

高度质瘤 (HGG) 复发是一个重大挑战,因为其具有攻击性和不良预后.
区分真正的瘤复发与与治疗相关的变化,如放射性死,是一个关键的诊断障碍.
机器学习 (ML) 为分析复杂的成像数据提供了一个有希望的途径,以提高诊断准确度.

研究的目的:

系统地审查和元分析ML算法在检测HGG复发中的诊断性能.
为了比较不同ML模型的有效性,特别是支持矢量机 (SVM),在区分瘤复发和治疗效果方面.

主要方法:

在主要数据库 (PubMed,Embase,Scopus,Web of Science,Google Scholar) 中进行了全面的文献搜索.
七项研究符合系统审查的资格标准,其中五项被纳入了元分析.
提取和分析了包括灵敏度,特异性和AUC在内的关键性能指标.

主要成果:

ML模型表现出高的诊断性能,聚合灵敏度为0.95和特异性为0.80.
与非SVM模型相比,支持矢量机器 (SVM) 的性能优越,灵敏度 (0.98) 和特异性 (0.82) 较高.
在ML模型中,曲线下的面积 (AUC) 为0.86,表明强大的诊断能力.

结论:

ML算法,特别是SVM,在准确区分HGG复发和与治疗相关的变化方面显示出显著的前景.
这些发现支持了ML作为HGG复发早期和准确诊断的有价值工具的潜力.
需要进一步的研究和临床验证,以将ML纳入常规的神经瘤实践.

关键词:

人工智能的人工智能是人工智能.大脑瘤是什么?高级质瘤是一种高级质瘤.机器学习机器学习预测预测预测复发情况复发情况

更多相关视频

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

相关概念视频

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...